Tatsuki Tomikawa

Kawagoe, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Real-world data of MDS and CMML in Japan: results of JALSG clinical observational study-11 (JALSG-CS-11).

Real-world data of MDS and CMML in Japan: results of JALSG clinical observational study-11 (JALSG-CS-11).

Journal: International journal of hematology

Published: August 26, 2023

Real-world data of AML in Japan: results of JALSG clinical observational study-11 (JALSG-CS-11).

Real-world data of AML in Japan: results of JALSG clinical observational study-11 (JALSG-CS-11).

Journal: International journal of hematology

Published: June 25, 2023

Outcomes of transplant-eligible patients with myelodysplastic syndrome with excess blasts registered in an observational study: The JALSG-CS11-MDS-SCT.

Outcomes of transplant-eligible patients with myelodysplastic syndrome with excess blasts registered in an observational study: The JALSG-CS11-MDS-SCT.

Journal: Annals of hematology

Published: May 12, 2023

Prognostic factors for the development of lower respiratory tract infection after influenza virus infection in allogeneic hematopoietic stem cell transplantation recipients: A Kanto Study Group for Cell Therapy multicenter analysis.

Prognostic factors for the development of lower respiratory tract infection after influenza virus infection in allogeneic hematopoietic stem cell transplantation recipients: A Kanto Study Group for Cell Therapy multicenter analysis.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

Published: September 08, 2022

The clinical impact of absolute lymphocyte count in peripheral blood among patients with methotrexate - associated lymphoproliferative disorders.

The clinical impact of absolute lymphocyte count in peripheral blood among patients with methotrexate - associated lymphoproliferative disorders.

Journal: Journal of clinical and experimental hematopathology : JCEH

Published: May 15, 2020

Prospective evaluation of prognostic impact of KIT mutations on acute myeloid leukemia with RUNX1-RUNX1T1 and CBFB-MYH11.

Prospective evaluation of prognostic impact of KIT mutations on acute myeloid leukemia with RUNX1-RUNX1T1 and CBFB-MYH11.

Journal: Blood advances

Published: July 15, 2019

Human parvovirus B19-induced hemophagocytic lymphohistiocytosis and myocarditis in an adult patient with hereditary spherocytosis

Human parvovirus B19-induced hemophagocytic lymphohistiocytosis and myocarditis in an adult patient with hereditary spherocytosis

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: July 06, 2018

The aggressive clinical courses of Hodgkin lymphoma primarily diagnosed as methotrexate-induced non-specific lymphoproliferative disorder in patients with rheumatoid arthritis.

The aggressive clinical courses of Hodgkin lymphoma primarily diagnosed as methotrexate-induced non-specific lymphoproliferative disorder in patients with rheumatoid arthritis.

Journal: Journal of clinical and experimental hematopathology : JCEH

Published: March 24, 2017

Successful early romiplostim use in a case of severe immune thrombocytopenia with critical carotid arterial injury.

Successful early romiplostim use in a case of severe immune thrombocytopenia with critical carotid arterial injury.

Journal: International journal of hematology

Published: May 27, 2016

Cardiac and breast diffuse large B-cell lymphoma with pericardial effusion and AV-block

Cardiac and breast diffuse large B-cell lymphoma with pericardial effusion and AV-block

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: March 10, 2015

Therapy-related myeloid neoplasm in methotrexate-associated lymphoproliferative disease in a rheumatoid arthritis patient.

Therapy-related myeloid neoplasm in methotrexate-associated lymphoproliferative disease in a rheumatoid arthritis patient.

Journal: Journal of clinical and experimental hematopathology : JCEH

Published: October 17, 2014

TM-233, a novel analog of 1'-acetoxychavicol acetate, induces cell death in myeloma cells by inhibiting both JAK/STAT and proteasome activities.

TM-233, a novel analog of 1'-acetoxychavicol acetate, induces cell death in myeloma cells by inhibiting both JAK/STAT and proteasome activities.

Journal: Cancer science

Published: September 22, 2014

Showing 1-12 of 12

Last Updated: 09/26/2026